Cargando…
Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy
Nanoparticles are useful delivery vehicles for promising drug candidates that face obstacles for clinical applicability. Sirolimus, an inhibitor of mammalian target of rapamycin has gained attention for targeted anticancer therapy, but its clinical application has been limited by its poor solubility...
Autores principales: | Woo, Ha Na, Chung, Hye Kyung, Ju, Eun Jin, Jung, Joohee, Kang, Hye-Won, Lee, Sa-Won, Seo, Min-Hyo, Lee, Jin Seong, Lee, Jung Shin, Park, Heon Joo, Song, Si Yeol, Jeong, Seong-Yun, Choi, Eun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356221/ https://www.ncbi.nlm.nih.gov/pubmed/22619555 http://dx.doi.org/10.2147/IJN.S29480 |
Ejemplares similares
-
Polymeric nanoparticle-docetaxel for the treatment of advanced solid tumors: phase I clinical trial and preclinical data from an orthotopic pancreatic cancer model
por: Song, Si Yeol, et al.
Publicado: (2016) -
Nanoparticulated docetaxel exerts enhanced anticancer efficacy and overcomes existing limitations of traditional drugs
por: Choi, Jinhyang, et al.
Publicado: (2015) -
Impact of nutritional index on contrast-associated acute kidney injury and mortality after percutaneous coronary intervention
por: Han, Miyeun, et al.
Publicado: (2021) -
NCK-associated protein 1 regulates metastasis and is a novel prognostic marker for colorectal cancer
por: Kwon, Mi Ri, et al.
Publicado: (2023) -
MERS-CoV Spike Protein Vaccine and Inactivated Influenza Vaccine Formulated with Single Strand RNA Adjuvant Induce T-Cell Activation through Intranasal Immunization in Mice
por: Kim, Hye-Jung, et al.
Publicado: (2020)